Affordable Access

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.

Authors
  • 1
  • 1 Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. [email protected]
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Publication Date
Volume
17
Issue
6
Pages
986–989
Identifiers
PMID: 16533874
Source
Medline
License
Unknown

Abstract

Zoledronic acid was more likely than placebo to be associated with clinically meaningful reductions in pain. Thus, zoledronic acid may help to avert the pain experienced by patients with progressing metastatic disease secondary to prostate cancer.

Statistics

Seen <100 times